The emotional and psychological impact of multiple sclerosis relapses

Journal of the Neurological Sciences

Volumn 256, Issue SUPPL. 1, 2007, Pages

  Kalb, Rosalind ^a  

^a National Multiple Sclerosis Society   (United States)

Author keywords

Emotional; Exacerbation; MS; Multiple sclerosis; Psychological; Relapse; Social

Indexed keywords

ADJUSTMENT; ARTICLE; CHILD PARENT RELATION; CHRONIC DISEASE; DECISION MAKING; DISABILITY; DISEASE COURSE; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; EMOTION; FAMILY; GRIEF; GUILT; HUMAN; MARRIAGE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; RELAPSE; SOCIAL ENVIRONMENT; TREATMENT PLANNING;

ADAPTATION, PSYCHOLOGICAL; CAREGIVERS; DENIAL (PSYCHOLOGY); DEPRESSIVE DISORDER; EMOTIONS; HUMANS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PSYCHOLOGY; QUALITY OF LIFE; RECURRENCE;

EID: 34147157332     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.01.061     Document Type: Article

References (19)

1. Foong J., Rozewicz L., Quaghebeur G., Thompson A.J., and Ron M.A. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 64 (1998) 529-532
2. Dalos N.P., Rabins P.V., Brooks B.R., and O'Donnell P. Disease activity and emotional state in multiple sclerosis. Ann Neurol 13 (1983) 573-577
3. Schiaffino K.M., Shawaryn M.A., and Blum D. Examining the impact of illness representations on psychological adjustment to chronic illness. Health Psychol 17 (1998) 262-268
4. Wineman N.M., Schwetz K.M., Goodkin D.E., and Rudick R.A. Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trial. Appl Nurs Res 9 (1996) 53-60
5. Devins G.M., Styra R., O'Connor P., Gray T., Seland T.P., Klein G.M., et al. Psychosocial impact of illness intrusiveness moderated by age in multiple sclerosis. Psychol Health Med 1 (1996) 179-191
6. Devins G.M., Edworthy S.M., Paul L.C., Mandin H., Seland T.P., Klein G., et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res 37 (1993) 163-170
7. Devins G.M., Edworthy S.M., Seland T.P., Klein G.M., Paul L.C., and Mandin H. Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Mental Dis 181 (1993) 377-381
8. Kalb R. When MS joins the family. In: Kalb R. (Ed). Multiple sclerosis: a guide for families. Third edition (2005), Demos Publishing, New York
9. LaRocca N. Emotional and cognitive issues. In: Kalb R. (Ed). Multiple sclerosis: a guide for families. Third edition (2005), Demos Medical Publishing, New York
10. Jacobs L.D., Beck R.W., Simon J.H., Kinkel R.P., Brownscheidle C.M., Murray T.J., et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343 (2000) 898-904
11. Comi G., et al., for the Early Treatment of Multiple Sclerosis Study Group. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study. Lancet 357 (2001) 1576-1582
12. Kappos L., et al., for the BENEFIT Study Group. Betaferon® in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT): clinical results. Presented at 21st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Thessaloniki, Greece, September 28-October 1 (2005)
13. Barkhof F., et al., for the BENEFIT Study Group. Betaferon® in Newly Emerging Multiple Sclerosis for Initial Treatment (BENEFIT): magnetic resonance imaging outcomes. Presented at 21st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Thessaloniki, Greece, September 28-October 1 (2005)
14. Deatrick J.A., Brennan D., and Cameron M.E. Mothers with multiple sclerosis and their children: effects of fatigue and exacerbations on maternal support. Nurs Res 47 (1998) 205-210
15. Goeb J.L., Even C., Nicolas G., Gohier B., Dubas F., and Garre J.B. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry 21 (2006) 186-193
16. Patten S.B., Francis G., Metz L.M., Lopez-Bresnahan M., Chang P., and Curtin F. The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis. Mult Scler 11 (2005) 175-181
17. Gold R., and for the PRISMS Study Group. The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study. Eur J Neurol 12 (2005) 649-656
18. Northrop D. Planning wisely for possible care needs. In: Kalb R. (Ed). Multiple sclerosis: a guide for families. Third edition (2005), Demos Medical Publishing, New York
19. Cooper L. Life planning: financial and legal considerations. In: Kalb R. (Ed). Multiple sclerosis: a guide for families. Third edition (2005), Demos Medical Publishing, New York